Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Theravance Biopharma, Inc. | 80,213 | reported | 12 Jun 2026 | tx 25+241,489−14,000 |
| PERRIGO Co plc | 0 | reported | 14 May 2026 | tx 53+159,258−97,519 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 Jun 2026 | GRANT_AWARD | Theravance Biopharma, Inc. | 6,009 | 0.00 USD | |
| 12 Jun 2026 | GRANT_AWARD | Theravance Biopharma, Inc. | 13,398 | 0.00 USD | deriv |
| 14 May 2026 | EXERCISE | PERRIGO Co plc | 7,305 | 10.84 USD | |
| 14 May 2026 | TAX_WITHHOLDING | PERRIGO Co plc | 3,507 | 10.84 USD | |
| 13 May 2026 | GRANT_AWARD | PERRIGO Co plc | 16,681 | — | deriv |
| 14 May 2026 | EXERCISE | PERRIGO Co plc | 7,305 | — | deriv |
| 19 May 2025 | GRANT_AWARD | Theravance Biopharma, Inc. | 10,649 | 0.00 USD | |
| 19 May 2025 | GRANT_AWARD | Theravance Biopharma, Inc. | 24,258 | 0.00 USD | deriv |
| 14 May 2025 | TAX_WITHHOLDING | PERRIGO Co plc | 4,754 | 26.01 USD | |
| 14 May 2025 | EXERCISE | PERRIGO Co plc | 9,904 | 26.01 USD | |
| 14 May 2025 | GRANT_AWARD | PERRIGO Co plc | 7,305 | — | deriv |
| 14 May 2025 | EXERCISE | PERRIGO Co plc | 9,904 | — | deriv |
| 15 May 2024 | EXERCISE | PERRIGO Co plc | 8,764 | 30.22 USD | |
| 15 May 2024 | TAX_WITHHOLDING | PERRIGO Co plc | 4,207 | 30.22 USD | |
| 15 May 2024 | EXERCISE | PERRIGO Co plc | 8,764 | — | deriv |
| 14 May 2024 | GRANT_AWARD | PERRIGO Co plc | 9,904 | — | deriv |
| 08 May 2024 | GRANT_AWARD | Theravance Biopharma, Inc. | 10,537 | 0.00 USD | |
| 08 May 2024 | GRANT_AWARD | Theravance Biopharma, Inc. | 23,576 | 0.00 USD | deriv |
| 17 May 2023 | TAX_WITHHOLDING | PERRIGO Co plc | 3,734 | 32.86 USD | |
| 17 May 2023 | EXERCISE | PERRIGO Co plc | 7,778 | 32.86 USD | |
| 17 May 2023 | EXERCISE | PERRIGO Co plc | 7,778 | — | deriv |
| 15 May 2023 | GRANT_AWARD | PERRIGO Co plc | 8,764 | — | deriv |
| 02 May 2023 | GRANT_AWARD | Theravance Biopharma, Inc. | 9,132 | 0.00 USD | |
| 02 May 2023 | GRANT_AWARD | Theravance Biopharma, Inc. | 22,044 | 0.00 USD | deriv |
| 22 Nov 2022 | OTHER | Theravance Biopharma, Inc. | 10,000 | 10.50 USD |